Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 4.900
+0.150 (3.16%)
Jun 18, 2026, 2:04 PM HKT
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 3.87 billion as of June 17, 2026. Its market cap has decreased by -33.72% in one year.
Market Cap
3.87B
Enterprise Value
3.63B
Revenue
895.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.90
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 3.87B, a decrease of -81.80%. That is a compound annual growth rate of -24.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 3.87B | -35.81% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Bao Pharmaceuticals | 5.88B |
| Guangzhou Innogen Pharmaceutical Group | 3.72B |
| Mirxes Holding Company | 3.66B |
| Jacobio Pharmaceuticals Group | 3.55B |
| Laekna | 3.45B |
| Qyuns Therapeutics | 3.21B |
| Medtide | 3.18B |
| Shandong Boan Biotechnology | 3.05B |